PEBC Reference Books
PEBC Reference Books
PEBC Reference Books
These four listings are all resources published by The Canadian Pharmacists Association
(www.pharmacists.ca) and are available in print and online (RxTx) versions.
The listings shown in the table below are major textbook references which form the framework for
many of the Canadian undergraduate pharmacy programs. For easy reference to search out a
reference in a particular subject, the titles are organized under the headings of the four major subject
areas of the Pharmacist Evaluating Examination Blueprint.
To obtain up to date evidence-based information designed to assist in patient care decisions for the
management of specific disease states, several Canadian practice guidelines are available. Some
examples are included in the following table.
Organization Website URL Guideline(s)
Hypertension Canada www.hypertension.ca • Hypertension
Canadian Cardiovascular www.ccs.ca • Various cardiovascular
Society diseases
Diabetes Canada www.diabetes.ca • Diabetes
Canadian Thoracic Society https://cts.lung.ca • Asthma
• COPD
American College of Chest • Antithrombotic therapy for
Physicians VTE disease
Professional Development
www.iehpcanada.utoronto.ca
Orientation course on the Canadian healthcare system for internationally educated healthcare
professionals
https://cpd.pharmacy.ubc.ca
https://learn.utoronto.ca/programs-courses/health-and-social-sciences/pharmacy
Continuous professional development for pharmacists
www.canadianhealthcarenetwork.ca
Canadian Healthcare Network - provides CE lessons from Pharmacy Practice and other sources
www.rxbriefcase.com
RxBriefCase - includes links to various CE learning resources
Most CE learning modules are designed to enhance individual knowledge in therapeutics and
disease state management. When choosing to self-study with CCEPP-approved CE learning
modules, it is important for a candidate to self-assess the wide range of available topics and make
selections to ensure that:
1) individual gaps in knowledge will be addressed, and
2) disease topics reflect those seen most frequently in patient care practice settings, as well
as those where drug therapy plays an important and critical role in patient care outcomes.